Sartorius, a leading international pharmaceutical and laboratory equipment provider, today announced the acquisition of U.S. based IntelliCyt Corporation, an award-winning innovator and manufacturer of novel cell screening platforms used in drug discovery.
Click below to view the latest news and updates from Arboretum Ventures.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a triangular-shaped minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced the closing of a $20 million round of growth capital financing. New investor Arboretum Ventures led the round and all of SI-BONE’s existing major investors participated.
The U.S. Food and Drug Administration (FDA) has granted commercial clearance for the Cerêve™ Sleep System, a prescription device that reduces latency to Stage 1 and Stage 2 sleep for people with insomnia.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System® (“iFuse”), a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the U.S. Food and Drug Administration (FDA) has cleared a 510(k) to allow modification of its indication statement noting that clinical studies have demonstrated that treatment with the iFuse Implant System improve pain, patient function and quality of life. The revised indication statement is based on extensive safety and effectiveness data from retrospective studies as well as three prospective clinical trials.
These 100 women manage budgets and civic initiatives. They lead in business, academia, nonprofits and public policy. They are CEOs, executive directors and company founders. Crain’s has been honoring influential women in metro Detroit since 1997; this year, we take that recognition statewide.
Strata Oncology, a precision medicine company, today announced the completion of a Series A financing of $12M. The financing will fuel Strata’s state-of-the-art tumor sequencing operation and implementation of the Strata Trial, a nation-wide effort aimed at substantially increasing the number of enrollments in precision medicine clinical trials. Arboretum Ventures and Baird Capital co-led the financing, with additional funding provided by Strata’s existing investor, Michigan eLab.